M1A.451 Other secondary chronic gout, right hip

Name of the Condition

• Other Secondary Chronic Gout, Right Hip

Summary

Other secondary chronic gout, right hip is a form of arthritis affecting the right hip joint, resulting from elevated uric acid levels due to an identifiable underlying condition or cause. It leads to recurrent joint inflammation and potential tissue damage, with symptoms that may persist over time. Advanced stages can involve the formation of tophi (urate crystal deposits) in the hip area.

Causes

Other secondary chronic gout, right hip arises from an underlying condition that disrupts uric acid metabolism, causing accumulation in the blood. This can stem from overproduction of uric acid or reduced renal clearance due to factors like chronic kidney disease, certain medications, or hematologic disorders. Over time, urate crystals deposit in the right hip joint and surrounding tissues, triggering inflammation.

Risk Factors

• Underlying conditions that affect uric acid metabolism (e.g., certain hematologic disorders, enzyme deficiencies)
• Medications that increase uric acid levels (e.g., some diuretics, chemotherapy agents)
• Chronic kidney disease or renal impairment
• History of gout or hyperuricemia
• Exposure to substances that disrupt uric acid excretion

Symptoms

• Recurrent episodes of intense hip pain, often with swelling and redness
• Persistent warmth and tenderness in the right hip
• Limited range of motion or stiffness in the hip joint
• Flare-ups triggered by stress, diet, or illness
• Possible formation of tophi (hard, painless lumps) in advanced cases

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history, and laboratory tests. Joint fluid analysis may be performed to identify urate crystals. Imaging studies, such as X-rays or ultrasound, can assess joint damage or tophi. Blood tests to measure uric acid levels and evaluate kidney function may also be used to confirm the underlying cause.

Treatment Options

Treatment focuses on managing symptoms and addressing the underlying cause. Medications like nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids may reduce inflammation during flare-ups. Long-term management may include urate-lowering therapies (e.g., allopurinol) to prevent crystal formation. Lifestyle modifications, such as dietary changes, are often recommended.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is important to monitor uric acid levels, adjust medications, and assess for complications. Untreated or poorly managed cases may lead to chronic joint damage or tophi formation.

Complications

• Chronic joint damage or deformity in the right hip
• Formation of tophi, which can cause pain or functional impairment
• Increased risk of kidney stones or renal impairment
• Recurrent flare-ups leading to reduced mobility

Lifestyle & Prevention

• Limit alcohol consumption, especially beer and spirits
• Reduce intake of high-purine foods (e.g., red meat, seafood)
• Maintain a healthy weight to reduce uric acid production
• Stay hydrated to support kidney function
• Follow prescribed medication regimens consistently

When to Seek Professional Help

Seek medical attention if you experience sudden, severe hip pain, swelling, or redness, or if symptoms persist despite home care. Prompt evaluation is important to prevent long-term joint damage.

Tips for Medical Coders

Document the specific site (right hip) and confirm the underlying cause of secondary gout. Ensure clinical documentation supports the diagnosis and any associated conditions. Code M1A.451 is specific to the right hip; verify no other site is documented to avoid miscoding.